S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Surgery Partners (SGRY) Earnings Date, Estimates & Call Transcripts

$23.83
+0.41 (+1.75%)
(As of 04/19/2024 08:51 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 7
Before Market Opens
Confirmed
Actual EPS
(Feb. 26)
$0.44 Beat By $0.07
Consensus EPS
(Feb. 26)
$0.37
Skip Charts & View Estimated and Actual Earnings Data

SGRY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SGRY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Surgery Partners Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.03$0.09$0.06 
Q2 20242$0.10$0.11$0.11 
Q3 20242$0.10$0.21$0.16 
Q4 20242$0.31$0.48$0.40 
FY 20248$0.54$0.89$0.72 
Q1 20251$0.11$0.11$0.11 
Q2 20251$0.18$0.18$0.18 
Q3 20251$0.29$0.29$0.29 
Q4 20251$0.55$0.55$0.55 
FY 20254$1.13$1.13 $1.13

SGRY Earnings Date and Information

Surgery Partners last posted its quarterly earnings results on February 26th, 2024. The reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.07. The company earned $735.40 million during the quarter, compared to the consensus estimate of $741.93 million. Its revenue for the quarter was up 4.0% compared to the same quarter last year. Surgery Partners has generated ($0.10) earnings per share over the last year (($0.10) diluted earnings per share). Earnings for Surgery Partners are expected to grow by 35.90% in the coming year, from $0.78 to $1.06 per share. Surgery Partners has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. Surgery Partners will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 412-317-6671 with passcode "13746011".

Surgery Partners Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Confirmed)
-------  
2/26/2024Q4 2023$0.3730$0.44+$0.0670$0.81$741.93 million$735.40 million      
11/7/2023Q3 2023$0.10$0.15+$0.05$0.34$670.74 million$674.10 million
8/1/2023Q2 2023$0.03$0.25+$0.22$0.35$667.94 million$667.60 million
5/1/2023Q1 2023($0.04)$0.05+$0.09$0.30$644.16 million$666.20 million
3/1/2023Q4 2022$0.16$0.22+$0.06$0.67$688.34 million$707.10 million    
11/8/2022Q3 2022($0.01)($0.08)($0.07)$0.12$622.97 million$620.60 million
8/2/2022Q2 2022($0.08)($0.08)-$0.05$624.64 million$615.40 million
5/3/2022Q1 2022($0.11)($0.13)($0.02)($0.40)$579.58 million$596.20 million      
2/28/2022Q4 2021$0.21$0.18($0.03)$0.36$625.91 million$610.20 million    
11/2/2021Q3 2021($0.09)($0.05)+$0.04$0.08$554.15 million$559.20 million    
8/4/2021Q2 2021($0.20)($0.52)($0.32)$0.27$545.08 million$543.30 million    
5/5/2021Q1 2021($0.30)($0.30)-($0.23)$505.22 million$512.40 million  

Surgery Partners Earnings - Frequently Asked Questions

When is Surgery Partners's earnings date?

Surgery Partners has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on SGRY's earnings history.

Did Surgery Partners beat their earnings estimates last quarter?

In the previous quarter, Surgery Partners (NASDAQ:SGRY) reported $0.44 earnings per share (EPS) to beat the analysts' consensus estimate of $0.37 by $0.07. Learn more on analysts' earnings estimate vs. SGRY's actual earnings.

How can I listen to Surgery Partners's earnings conference call?

The conference call for Surgery Partners's latest earnings report can be listened to online. Listen to Conference Call

How can I read Surgery Partners's conference call transcript?

The conference call transcript for Surgery Partners's latest earnings report can be read online. Read Transcript

How can I view Surgery Partners's earnings report?

Surgery Partners's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Surgery Partners generate each year?

Surgery Partners (NASDAQ:SGRY) has a recorded annual revenue of $2.74 billion.

How much profit does Surgery Partners generate each year?

Surgery Partners (NASDAQ:SGRY) has a recorded net income of -$11.90 million. SGRY has generated -$0.10 earnings per share over the last four quarters.

What is Surgery Partners's price-to-earnings ratio?

Surgery Partners (NASDAQ:SGRY) has a forward price-to-earnings ratio of 30.55. The price/earnings-to-growth ratio is 2.18.

What is Surgery Partners's EPS forecast for next year?

Surgery Partners's earnings are expected to grow from $0.78 per share to $1.06 per share in the next year, which is a 35.90% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:SGRY) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners